- Retrospective analysis of intensity-modulated radiotherapy and three-dimensional conformal radiotherapy of postoperative treatment for biliary tract cancer
-
Lee HC, Lee JH, Lee SW, Lee JH, Yu M, Jang HS, Kim SH
- KMID: 2468737
- Radiat Oncol J.
- 2019 Dec;37(4):279-285.
- doi: 10.3857/roj.2019.00430
PURPOSE: This study was conducted to compare the outcome of three-dimensional conformal radiotherapy (3D-CRT) and intensity-modulated radiotherapy (IMRT) for the postoperative treatment of biliary tract cancer. MATERIALS AND METHODS: From February... -
- CITED
-
- Close
- SHARE
-
- Close
- Safety Evaluation of Paclitaxel-Eluting Biliary Metal Stent with Sodium Caprate in Porcine Biliary Tract
-
Jang SI, Jeong S, Lee DH, Na K, Yang S, Lee DK
- KMID: 2458531
- Gut Liver.
- 2019 Jul;13(4):471-478.
- doi: 10.5009/gnl18454
BACKGROUND/AIMS: Metallic stents designed to relieve malignant biliary obstruction are susceptible to occlusive tumor ingrowth or overgrowth. In a previous report, we described metallic stents covered with paclitaxel-incorporated membrane (MSCPM-I,... -
- CITED
-
- Close
- SHARE
-
- Close
- Therapeutic Targeting of the DNA Damage Response Using an ATR Inhibitor in Biliary Tract Cancer
-
Nam AR, Jin MH, Park JE, Bang JH, Oh DY, Bang YJ
- KMID: 2454308
- Cancer Res Treat.
- 2019 Jul;51(3):1167-1179.
- doi: 10.4143/crt.2018.526
PURPOSE: The DNA damage response (DDR) is a multi-complex network of signaling pathways involved in DNA damage repair, cell cycle checkpoints, and apoptosis. In the case of biliary tract cancer... -
- CITED
-
- Close
- SHARE
-
- Close
- Clinical Benefit of Maintenance Therapy for Advanced Biliary Tract Cancer Patients Showing No Progression after First-Line Gemcitabine Plus Cisplatin
-
Hyung J, Kim B, Yoo C, Kim KP, Jeong JH, Chang HM, Ryoo BY
- KMID: 2454282
- Cancer Res Treat.
- 2019 Jul;51(3):901-909.
- doi: 10.4143/crt.2018.326
PURPOSE: Gemcitabine plus cisplatin (GemCis) is the standard first-line chemotherapy for patients with advanced biliary tract cancer (BTC). In ABC-02 study, the BTC patients received up to 6-8 cycles of... -
- CITED
-
- Close
- SHARE
-
- Close
- Jab1 Silencing Inhibits Proliferation and Sensitizes to Cisplatin in Biliary Tract Cancer
-
Nam AR, Kim JW, Park JE, Bang JH, Jin MH, Oh DY, Bang YJ
- KMID: 2454281
- Cancer Res Treat.
- 2019 Jul;51(3):886-900.
- doi: 10.4143/crt.2018.375
PURPOSE: Jab1 is a coactivator of c-Jun that enhances the transcriptional function of c-Jun. Jab1 is frequently overexpressed in various cancers and is associatedwith poor prognosis of cancer patients. Thus,... -
- CITED
-
- Close
- SHARE
-
- Close
- Incidence and Overall Survival of Biliary Tract Cancers in South Korea from 2006 to 2015: Using the National Health Information Database
-
Kim BW, Oh CM, Choi HY, Park JW, Cho H, Ki M
- KMID: 2434397
- Gut Liver.
- 2019 Jan;13(1):104-113.
- doi: 10.5009/gnl18105
BACKGROUND/AIMS: There have been no nationwide studies to investigate the trends in incidence and 5-year survival rates of intra- and extrahepatic bile duct cancers and gall-bladder cancer. Therefore, our study... -
- CITED
-
- Close
- SHARE
-
- Close
- Somatic Mutations from Whole Exome Sequencing Analysis of the Patients with Biliary Tract Cancer
-
Yoon KA, Woo SM, Kim YH, Kong SY, Han SS, Park SJ, Lee WJ
- KMID: 2439225
- Genomics Inform.
- 2018 Dec;16(4):e35.
- doi: 10.5808/GI.2018.16.4.e35
Biliary tract cancer (BTC) is a rare cancer and is associated with a poor prognosis. To understand the genetic characteristics of BTC, we analyzed whole-exome sequencing data and identified somatic... -
- CITED
-
- Close
- SHARE
-
- Close
- Imaging diagnosis of extrahepatic biliary tract obstruction with acquired portosystemic shunt in a cat
-
Hwang TS, Jang WS, Yoon YM, Jung DI, Lee HC
- KMID: 2437699
- Korean J Vet Res.
- 2018 Dec;58(4):227-230.
- doi: 10.14405/kjvr.2018.58.4.227
A 2-year-old, spayed female, Korean domestic short-hair cat was presented with depression and vomiting. The patient had history of weight loss lasting seven months. Physical examination revealed icterus in the... -
- CITED
-
- Close
- SHARE
-
- Close
- Thromboembolic Events as Prognostic Clinical Markers in Advanced Pancreatic and Biliary Tract Cancer
-
Shin K, Lee MA
- KMID: 2446988
- Korean J Med.
- 2018 Oct;93(5):457-463.
- doi: 10.3904/kjm.2018.93.5.457
BACKGROUND/AIMS: Venous thromboembolic events (VTEs) are common events in patients with advanced cancer. We analyzed the clinical characteristics of VTEs in advanced pancreatic and biliary tract cancer to determine the... -
- CITED
-
- Close
- SHARE
-
- Close
- Multicenter Phase II Study of Oxaliplatin, Irinotecan, and S-1 as First-line Treatment for Patients with Recurrent or Metastatic Biliary Tract Cancer
-
Yoo C, Han B, Kim HS, Kim KP, Kim D, Jeong JH, Lee JL, Kim TW, Kim JH, Choi DR, Ha HI, Seo J, Chang HM, Ryoo BY, Zang DY
- KMID: 2424804
- Cancer Res Treat.
- 2018 Oct;50(4):1324-1330.
- doi: 10.4143/crt.2017.526
PURPOSE: Although gemcitabine plus cisplatin has been established as the standard first-line chemotherapy for patients with advanced biliary tract cancer (BTC), overall prognosis remains poor. We investigated the efficacy of... -
- CITED
-
- Close
- SHARE
-
- Close
- Chemotherapy versus Best Supportive Care in Advanced Biliary Tract Carcinoma: A Multi-institutional Propensity Score Matching Analysis
-
Ji JH, Kim YS, Park I, Lee SI, Kim RB, Park JO, Oh SY, Hwang IG, Jang JS, Song HN, Kang JH
- KMID: 2417868
- Cancer Res Treat.
- 2018 Jul;50(3):791-800.
- doi: 10.4143/crt.2017.044
PURPOSE: Although chemotherapy is recommended by various guidelines for advanced biliary tract cancer (BTC), the evidence supporting its use over best supportive care (BSC) is limited. The aim of this... -
- CITED
-
- Close
- SHARE
-
- Close
- Liver Fluke-Associated Biliary Tract Cancer
-
Prueksapanich P, Piyachaturawat P, Aumpansub , Ridtitid W, Chaiteerakij R, Rerknimitr R
- KMID: 2411668
- Gut Liver.
- 2018 May;12(3):236-245.
- doi: 10.5009/gnl17102
Cholangiocarcinoma (CCA) is an aggressive cancer arising from epithelial cells of the bile duct. Most patients with CCA have an unresectable tumor at the time of diagnosis. In Western countries,... -
- CITED
-
- Close
- SHARE
-
- Close
- Comparison of Outcomes between 7-French and 10-French Plastic Stents for Patients with Biliary Tract Cancer
-
Lee KJ, Kang YS, Seong JH, Jung S, Kim JW
- KMID: 2448613
- Korean J Pancreas Biliary Tract.
- 2017 Oct;22(4):165-171.
- doi: 10.15279/kpba.2017.22.4.165
BACKGROUND/AIM: There is little data on whether plastic stents with a larger diameter are patent for longer than small stents in patients with bile duct cancer. The aim of this... -
- CITED
-
- Close
- SHARE
-
- Close
- Prognostic Factors and Scoring Model for Survival in Metastatic Biliary Tract Cancer
-
Park HS, Park JS, Chun YJ, Roh YH, Moon J, Chon HJ, Choi HJ, Park JS, Lee DK, Lee SJ, Yoon DS, Jeung HC
- KMID: 2394831
- Cancer Res Treat.
- 2017 Oct;49(4):1127-1139.
- doi: 10.4143/crt.2016.538
PURPOSE: Metastatic biliary tract cancer (mBTC) has a dismal prognosis. In this study, an independent dataset of patients with mBTC was used to implement and validate a routine clinico-laboratory parameter-based... -
- CITED
-
- Close
- SHARE
-
- Close
- CA19-9 or CEA Decline after the First Cycle of Treatment Predicts Survival in Advanced Biliary Tract Cancer Patients Treated with S-1 and Cisplatin Chemotherapy
-
Lee DW, Im SA, Kim YJ, Yang Y, Rhee J, Na II, Lee KH, Kim TY, Han SW, Choi IS, Oh DY, Kim JH, Kim TY, Bang YJ
- KMID: 2388326
- Cancer Res Treat.
- 2017 Jul;49(3):807-815.
- doi: 10.4143/crt.2016.326
PURPOSE: While tumor markers (carbohydrate antigen 19-9 [CA 19-9] and carcinoembryonic antigen [CEA]) can aid in the diagnosis of biliary tract cancer, their prognostic role has not been clearly elucidated.... -
- CITED
-
- Close
- SHARE
-
- Close
- Chemotherapy for Biliary Tract Cancer
-
Woo SM
- KMID: 2383410
- Korean J Gastroenterol.
- 2017 Mar;69(3):172-176.
- doi: 10.4166/kjg.2017.69.3.172
The term of biliary tract cancer (BTC) refers to all tumors that arise from the biliary tract or the biliary drainage system, including the intra- and extra-hepatic bile ducts as... -
- CITED
-
- Close
- SHARE
-
- Close
- Clinical implications of APEX1 and Jagged1 as chemoresistance factors in biliary tract cancer
-
Kim HB, Cho WJ, Choi NG, Kim SS, Park JH, Lee HJ, Park SG
- KMID: 2364709
- Ann Surg Treat Res.
- 2017 Jan;92(1):15-22.
- doi: 10.4174/astr.2017.92.1.15
PURPOSE: Biliary cancer is a highly malignant neoplasm with poor prognosis and most patients need to undergo palliative chemotherapy, however major clinical problem associated with the use of chemotherapy is... -
- CITED
-
- Close
- SHARE
-
- Close
- Metastasectomy for Recurrent or Metastatic Biliary Tract Cancers: A Single Center Experience
-
Kim J, Jang Y, Shim J, Yu J, Shin DB, Park I
- KMID: 2328771
- Soonchunhyang Med Sci.
- 2016 Jun;22(1):1-7.
- doi: 10.0000/sms.2016.22.1.1
OBJECTIVE: Efficacy or long-term result of metastasectomy for recurrent or metastatic biliary tract carcinoma (BTC) is not well established. We conducted a retrospective review of the outcomes of metastasectomy for... -
- CITED
-
- Close
- SHARE
-
- Close
- Second-Line Chemotherapy in Advanced Biliary Tract Cancer: A Retrospective Analysis
-
Kim HJ, Yun J, Kim HJ, Kim KH, Kim SH, Lee SC, Bae SB, Kim CK, Lee NS, Lee KT, Park SK, Won JH, Choi HJ, Moon JH, Hong DS
- KMID: 2317760
- Soonchunhyang Med Sci.
- 2015 Dec;21(2):75-81.
- doi: 10.0000/sms.2015.21.2.75
OBJECTIVE: The evidence of 2nd line chemotherapy has not been validated. We investigated the treatment outcomes of 2nd line palliative chemotherapy in patients with biliary tract cancer (BTC) and analyzed... -
- CITED
-
- Close
- SHARE
-
- Close
- Advanced Imaging Technology in Biliary Tract Diseases:Narrow-Band Imaging of the Bile Duct
-
Choi HJ, Moon JH, Lee YN
- KMID: 2380406
- Clin Endosc.
- 2015 Nov;48(6):498-502.
- doi: 10.5946/ce.2015.48.6.498
Newly introduced direct peroral cholangioscopy and the development of video choledochoscopes have enabled more defined observation of bile duct mucosal lesions with clearer images. Narrow-band imaging (NBI) is a unique... -
- CITED
-
- Close
- SHARE
-
- Close
